ARTEMIS-102: HS-20093 Combinations in Patients with Advanced Metastatic Colorectal Cancer
- Status
- RECRUITING
- Phase
- PHASE1
Clinical Trials Related to Bevacizumab
Related studies linked through entity extraction aliases.
A Study to Evaluate the Efficacy and Safety of Sacituzumab Tirumotecan (MK-2870) Maintenance Treatment Versus Standard of Care in Participants With Platinum-sensitive Recurrent Ovarian Cancer (MK-2870-022/TroFuse-022/ENGOT-ov84/GOG-3103)
- Status
- RECRUITING
- Phase
- PHASE3
A Study to Evaluate the Adverse Events, and Efficacy of Intravenous (IV) of Telisotuzumab Adizutecan in Combination With IV Oxaliplatin, Fluorouracil, Folinic Acid/Leucovorin, Bevacizumab, Panitumumab in Adult Participants With Metastatic Colorectal Cancer
- Status
- RECRUITING
- Phase
- PHASE2
Study of Trastuzumab Deruxtecan With Bevacizumab Versus Bevacizumab Monotherapy for First-line Maintenance in HER2-Expressing Ovarian Cancer (DESTINY-Ovarian01)
- Status
- RECRUITING
- Phase
- PHASE3
A Study of Mocertatug Rezetecan in Combination With Anti-cancer Therapies for Advanced Solid Tumors
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
A Study of Novel Study Interventions and Combinations in Participants With Colorectal Cancer
- Status
- RECRUITING
- Phase
- PHASE2
The Study of Atezolizumab, Bevacizumab and Memantine in Patients With Hepatocellular Carcinoma (HCC)
- Status
- RECRUITING
- Phase
- PHASE2
PULSAR Combined With PD-1 Ab and Chemotherapy Plus Bev. for CRLM
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
Investigation of Ubamatamab Combination Therapy in Adult Participants With Platinum-Resistant Ovarian Cancer
- Status
- RECRUITING
- Phase
- PHASE2
QL1706 Plus Chemotherapy +/- Bevacizumab in 1L Treatment of R/mTNBC
- Status
- RECRUITING
- Phase
- PHASE2
Trial of Atezolizumab, Bevacizumab, and Tiragolumab in Patients With Microsatellite Stable, Metastatic Colorectal Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Liposomal Irinotecan + Oxaliplatin + Bevacizumab Versus Liposomal Irinotecan + 5-FU/LV
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
A Study of Adebrelimab in Combination with Chemo with or Without Bevacizumab Neoadjuvant Therapy for Resectable NSCLC
- Status
- RECRUITING
- Phase
- PHASE2
Safety and Efficacy of HCB101 in Combination With Multiple Agents in Patients With Advanced Solid Tumors
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1/PHASE2
Oral Chemotherapy, Targeted Therapy and Immunotherapy With/Without Radiotherapy as 3rd- or Later-line Therapy for Advanced MSS/pMMR Colorectal Cancer
- Status
- RECRUITING
- Phase
- PHASE2
A Study of Amivantamab and FOLFIRI Versus Cetuximab/Bevacizumab and FOLFIRI in Participants With KRAS/NRAS and BRAF Wild-type Colorectal Cancer Who Have Previously Received Chemotherapy
- Status
- RECRUITING
- Phase
- PHASE3
Bevacizumab Neoadjuvant Therapy for New High-grade Gliomas in the Brain
- Status
- RECRUITING
- Phase
- NA
PD-L1 Antibody + Bevacizumab With Hepatic Arterial Infusion Chemotherapy for Advanced HCC
- Status
- RECRUITING
- Phase
- PHASE2
Fluzoparib With or Without Bevacizumab for Neoadjuvant Therapy in Advanced Ovarian Cancer
- Status
- RECRUITING
- Phase
- PHASE2
FOLFOXIRI Plus Bevacizumab With or Without Atezolizumab as 1st Line Treatment of pMMR and IS IC-High Metastatic Colorectal Cancer Patients.
- Status
- RECRUITING
- Phase
- PHASE3